Fig. 2From: Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCThe effect of mosliciguat with DEA/NO and ODQ on isolated HC and HF rat sGC in vitro specific activity (left) and stimulation (right). DEA/NO diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate, HC heme-containing, HF heme-free, ODQ 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one, sGC soluble guanylate cyclase Back to article page